El trading conlleva riesgos
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El trading conlleva riesgos
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
GE HealthCare Technologies
Cerrado
Sector Salud
81.39 -2.89
Resumen
Variación precio
24h
Mínimo
81.11
Máximo
84.02
Ingresos | 268M 738M |
|---|---|
Ventas | 456M 5.3B |
P/B Media del Sector | 19.897 72.392 |
BPA | 1.45 |
Rentabilidad por dividendo | 0.16 |
Margen de beneficio | 13.875 |
Empleados | 53,000 |
EBITDA | 154M 1.1B |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 meses | +17.86 upside |
Rentabilidad por dividendo Media del Sector | 0.16% 3.07% |
|---|---|
Próximas Ganancias | 29 abr 2025 |
Próxima Fecha de Ex Dividendo | 17 abr 2025 |
Capitalización de Mercado | -1B 40B |
|---|---|
Apertura anterior | 84.28 |
Cierre anterior | 81.39 |
Noticias sobre sentimiento de mercado
By Acuity
10%
90%
6 / 393 Clasificación en Healthcare
GE HealthCare Technologies Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
GE HealthCare Technologies Esperado
Precio Objetivo
By TipRanks
17.86% repunte
Estimación a 12 meses
Media 100.88 USD 17.86%
Máximo 110 USD
Mínimo 86 USD
De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para GE HealthCare Technologies Dist en los últimos 3 meses.
Sentimiento
By Acuity
6 / 393 Clasificación en Salud
Noticias sobre sentimiento de mercado
Coyuntura alcista notoria
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por encima de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de GE HealthCare Technologies
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
